Printer Friendly
The Free Library
19,595,259 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Columbia Laboratories to Webcast Presentation at Undervalued Equities Conference in NYC on March 22.


LIVINGSTON, N.J. -- Columbia Laboratories, Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:CBRX) will present at the upcoming Friedland Capital Undervalued Undervalued

A stock or other security that is trading below its true value.

Notes:
The difficulty is knowing what the "true" value actually is. Analysts will usually recommend an undervalued stock with a strong buy rating.
 Equities Conference. Fred Wilkinson, president and chief executive officer of Columbia Laboratories, will provide an update on recent corporate events.
Date:             Tuesday, March 22, 2005
      Time:             10:30 a.m. Eastern Time
      Venue:            The Harvard Club of New York
      Live webcast:     www.columbialabs.com, under the Events tab


A replay of the webcast will be available immediately following the presentation for one year on Columbia Laboratories website, www.columbialabs.com, under the Events tab.

About Columbia Laboratories

Columbia Laboratories, Inc. is a U.S.-based international pharmaceutical company dedicated to the development and commercialization of women's health care and endocrinology products. Columbia markets Prochieve(R) 8% (progesterone gel) for progesterone supplementation as part of an Assisted Reproductive Technology Assisted reproductive technology (ART) is a general term referring to methods used to achieve pregnancy by artificial or partially artificial means. It is reproductive technology used in infertility treatment, which is the only application routinely used today of  treatment for infertile women with progesterone deficiency and Prochieve(R) 4% (progesterone gel) for the treatment of secondary amenorrhea. The Company also markets Striant(R) (testosterone buccal system) for the treatment of hypogonadism Hypogonadism Definition

Hypogonadism is the condition more prevalent in males in which the production of sex hormones and germ cells are inadequate.
 in men. Columbia's products and product candidates utilize the company's bioadhesive drug delivery technology, which is able to deliver a broad range of compounds, including peptides, across many of the body's mucosal surfaces to address numerous therapeutic areas. The Company is investigating the potential utility of Prochieve 8% in the prevention of preterm birth and developing a vaginally-administered lidocaine lidocaine /li·do·caine/ (li´do-kan) an anesthetic with sedative, analgesic, and cardiac depressant properties, applied topically in the form of the base or hydrochloride salt as a local anesthetic; also used in the latter form as a  product to treat dysmenorrhea dysmenorrhea

Pain or cramps before or during menstruation. In primary dysmenorrhea, caused by endocrine imbalances, severity varies widely. Irritability, fatigue, backache, or nausea may also occur.
 and pelvic pain. For more information, please visit www.columbialabs.com.

Striant(R) and Prochieve(R) are registered trademarks of Columbia Laboratories, Inc.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Mar 10, 2005
Words:253
Previous Article:Anteon Awarded $47M Contract to Provide Program Management and Systems Engineering Support to U.S. Navy.
Next Article:March Communications Takes Great Strides with Key Client Wins and Strategic Hires.
Topics:



Related Articles
Levine Builders hits Harlem home run.
Columbia Laboratories, Inc. Schedules Fourth Quarter and Year End 2001 Earnings Release and Conference Call.
Columbia Laboratories Scheduled to Present At the Banc of America Securities Healthcare Conference On April 2, 2002.
Columbia Laboratories Scheduled to Present at the CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference On May 2, 2002.
Kurt Eichler of LCOR, Inc.
Columbia Laboratories to Present at the Banc of America Securities Healthcare Conference.
Gov to 'study' proposals.
The Immune Response Corp. to Present at Wall Street Analyst Forum 51st NYC Analyst Conference.
Curis to Present at Rodman & Renshaw Techvest Global Healthcare Conference.
Columbia Laboratories to Present at Undervalued Equities Conference at 12:15 p.m. on March 22.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles